Robert Radinsky - Concepedia

Author

Robert Radinsky

The University of Texas MD Anderson Cancer Center

Also Known As

Hernandez, R RADINSKY, R Radinsky, R. Radinsky, ROBERT RADINSKY, Robert Radinsky

229

Publications

14.2K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Amgen (United States)Centre for Cancer Biology Society of Surgical Oncology Case Western Reserve University

About

Robert Radinsky is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	62	7.7K
2	Cell Biology	29	43	5.7K
3	Health Sciences	6	6	454
4	Biochemistry	5	5	154
5	Natural Sciences	4	4	120

Robert Radinsky

Publications

12.9K

Citations

H-Index

Page 1

	Year	Citations
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Rafael G. Amado, Michael Wolf, Marc Peeters, Journal of Clinical Oncology	2008	3.1K
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression Laurie B. Owen‐Schaub, Wei Zhang, James C. Cusack, Molecular and Cellular Biology ApoptosisImmunologyLung AdenocarcinomaCell DeathMolecular Biology	1995	731
Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Paul Perrotte, Takayuki Matsumoto, Keiji Inoue, PubMed Tumor BiologyAngiogenesisNude MiceMab C225 TherapyGenitourinary Cancer	1999	601
Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Christiane J. Bruns, Carmen C. Solórzano, Matthew T. Harbison, PubMed Endothelial CellsChemoprevention StrategyPathologyCell DeathLiver Metastasis	2000	501
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2 Jonathan D. Oliner, Hosung Min, Juan Leal, Cancer Cell Selective InhibitionAngiogenesisMedicineTumor GrowthVascular Biology	2004	467
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Christiane J. Bruns, Matthew T. Harbison, Darren W. Davis, PubMed PathologyDermatologyAnti-egf-r Antibody C225Cancer BiologyTumor Biology	2000	422
Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Rakesh K. Singh, Mordechai Gutman, Robert Radinsky, PubMed Protein SecretionImmunologyPathologyImmunologic MechanismDermatology	1994	364
Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Keiji Inoue, Joel W. Slaton, Beryl Y. Eve, PubMed ImmunologyImmunologic MechanismCancer BiologyTumor BiologyInflammation	2000	362
Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Robert Radinsky, Semyon A. Risin, Dominic Fan, PubMed Surgical OncologyPathologyGrowth Factor AlphaLiver MetastasisCancer Biology	1995	324
AMG 706, an Oral, Multikinase Inhibitor that Selectively Targets Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors, Potently Inhibits Angiogenesis and Induces Regression in Tumor Xenografts Anthony Polverino, Angela Coxon, Charlie Starnes, Cancer Research Tumor XenograftsPharmacotherapyTumor BiologyAngiogenesisFibroblast Growth Factor	2006	283

Page 1